期刊文献+

Wilson's disease: A review of what we have learned 被引量:10

Wilson's disease: A review of what we have learned
下载PDF
导出
摘要 Wilson's disease(WD), which results from the defective ATP7 B protein product, is characterized by impaired copper metabolism and its clinical consequences vary from an asymptomatic state to fulminant hepatic failure, chronic liver disease with or without cirrhosis, neurological, and psychiatric manifestations. A high grade of suspicion is warranted to not miss cases of WD, especially less florid cases with only mild elevation of transaminases, or isolated neuropsychiatric involvement. Screening in first and second relatives of index cases is mandatory, and treatment must commence upon establishment of diagnosis. Treatment strategies include chelators such as D-penicillamine and trientine, while zinc salts act as inductors of methallothioneins, which favor a negative copper balance and a reduction of free plasmatic copper. As an orphan disease, research is lacking in this field, especially regarding therapeutic strategies which are associated with better patient compliance and which could eventually also reverse established injury. Wilson's disease(WD), which results from the defective ATP7 B protein product, is characterized by impaired copper metabolism and its clinical consequences vary from an asymptomatic state to fulminant hepatic failure, chronic liver disease with or without cirrhosis, neurological, and psychiatric manifestations. A high grade of suspicion is warranted to not miss cases of WD, especially less florid cases with only mild elevation of transaminases, or isolated neuropsychiatric involvement. Screening in first and second relatives of index cases is mandatory, and treatment must commence upon establishment of diagnosis. Treatment strategies include chelators such as D-penicillamine and trientine, while zinc salts act as inductors of methallothioneins, which favor a negative copper balance and a reduction of free plasmatic copper. As an orphan disease, research is lacking in this field, especially regarding therapeutic strategies which are associated with better patient compliance and which could eventually also reverse established injury.
出处 《World Journal of Hepatology》 CAS 2015年第29期2859-2870,共12页 世界肝病学杂志(英文版)(电子版)
关键词 Wilson's DISEASE WILSON DISEASE Chelatingagents PENICILLAMINE Zinc Copper ORPHAN DISEASE Liver TRANSPLANTATION Wilson's disease Wilson disease Chelating agents Penicillamine Zinc Copper Orphan disease Liver transplantation
  • 相关文献

参考文献143

  • 1Wilson S. Progressive lenticular degeneration: A familial nervousdisease associated with cirrhosis of the liver. Brain 1912: 295-509.
  • 2Yang FM, Friedrichs WE, Cupples RL, Bonifacio MJ, Sanford JA,Horton WA, Bowman BH. Human ceruloplasmin. Tissue-specificexpression of transcripts produced by alternative splicing. J BiolChem 1990; 265: 10780-10785 [PMID: 2355023].
  • 3Rosencrantz R, Schilsky M. Wilson disease: pathogenesisand clinical considerations in diagnosis and treatment. SeminLiver Dis 2011; 31: 245-259 [PMID: 21901655 DOI: 10.1055/s-0031-1286056].
  • 4Hoogenraad TU. Paradigm shift in treatment of Wilson disease:zinc therapy now treatment of choice. Brain Dev 2006; 28:141-146 [PMID: 16466879 DOI: 10.1016/j.braindev.2005.08.008].
  • 5Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson抯disease. Lancet 2007; 369: 397-408 [PMID: 17276780 DOI: 10.1016/S0140-6736(07)60196-2].
  • 6Scheinberg IH, Sternlieb I. Wilson disease. In: Smith JL, editor.Major problems in internal medicine. Philadelphia: WB Saunders,1984: 25-35.
  • 7Scheinberg I, Sternlieb I. Wilson Disease. In: Lloyd H, SmithJ, editors. Major Problems in Internal Medicine. Saunders:Philadelphia, 1984: 23.
  • 8University of Alberta Wilson Disease Mutation Database [Internet].Available from: URL: http://www.wilsondisease.med.ualberta.ca/database.
  • 9Caca K, Ferenci P, Kn HJ, Polli C, Willgerodt H, Kunath B,Hermann W, Msner J, Berr F. High prevalence of the H1069Qmutation in East German patients with Wilson disease: rapiddetection of mutations by limited sequencing and phenotypegenotypeanalysis. J Hepatol 2001; 35: 575-581 [PMID: 11690702].
  • 10Kim EK, Yoo OJ, Song KY, Yoo HW, Choi SY, Cho SW, HahnSH. Identification of three novel mutations and a high frequency ofthe Arg778Leu mutation in Korean patients with Wilson disease.Hum Mutat 1998; 11: 275-278 [PMID: 9554743].

同被引文献54

引证文献10

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部